c-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells

Clin Exp Metastasis. 2003;20(5):421-30. doi: 10.1023/a:1025404603315.

Abstract

To further characterize the role of hepatocyte growth factor-scatter factor (HGF-SF) and its receptor (c-Met) in osteosarcoma (OS), human OS cell lines with low (SAOS-2) and high (SAOS-LM2) metastatic potential, and cell lines derived from spontaneous canine OS were studied. All cell lines were evaluated for c-Met and HGF-SF expression and receptor activation using Northern, RT-PCR, and Western blot analyses, respectively. Functional activity of receptor-ligand interaction was measured using c-Met phosphorylation status, proliferation assays (anchorage-dependent and -independent), Matrigel invasion, modulation of urokinase plasminogen activator (uPA) expression, and cell dispersion (scattering). All cell lines exhibited steady-state mRNA expression of c-Met. The canine OS cell lines also expressed HGF-SF mRNA as determined by RT-PCR analysis. Western analysis showed c-Met protein expression and HGF-stimulated (human) or constitutive (canine) receptor autophosphorylation. Treatment with recombinant human HGF resulted in enhanced proliferation in 3 of 5 OS cell lines and enhanced colony formation in 2 of 5 OS cell lines. Matrigel invasion was significantly enhanced in 3 of the cell lines and uPA levels were significantly increased in the SAOS-2 cells following HGF treatment. Scattering was enhanced in both the SAOS-2 and SAOS-LM2 cells. These data support the involvement of c-Met and HGF-SF in the growth and progression of human and canine OS, and may offer new targets for the development of therapeutic strategies for OS.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Blotting, Northern
  • Blotting, Western
  • Cell Division
  • Collagen / pharmacology
  • Dogs
  • Drug Combinations
  • Hepatocyte Growth Factor / physiology
  • Humans
  • Laminin / pharmacology
  • Ligands
  • Neoplasm Metastasis
  • Nucleic Acid Hybridization
  • Osteosarcoma / metabolism*
  • Phosphorylation
  • Proteoglycans / pharmacology
  • Proto-Oncogene Proteins c-met / biosynthesis*
  • Proto-Oncogene Proteins c-met / physiology*
  • RNA, Messenger / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tumor Cells, Cultured
  • Urokinase-Type Plasminogen Activator / biosynthesis

Substances

  • Drug Combinations
  • Laminin
  • Ligands
  • Proteoglycans
  • RNA, Messenger
  • matrigel
  • Hepatocyte Growth Factor
  • Collagen
  • Proto-Oncogene Proteins c-met
  • Urokinase-Type Plasminogen Activator